MCL

Outreach management is not taught in a formal training program. The path can be diverse, with different means and methods for success. Whether you inherited an outreach program or have built one from the ground up, here are seven tips to improve your success.

Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and characterize patients’ marijuana use.

Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all four have been shown to respond to immunotherapy.

Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.

In this month's "Hot Topic," Elitza Theel, Ph.D., shares the recommended approach to serologic testing for assessment or infection with coccidioides.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Cori Berg, M.S.N., R.N., instructor in nursing for the Center for Individualized[...]

This page includes updates posted to the site during the month of January.

Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Jennifer Storlie, operations manager of Inpatient Laboratory Services at Mayo Clinic in Rochester, Minnesota, to talk about workforce stability and strategies for retention.

As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their patients.

PACE
In this month’s “Virtual Lecture” Eoin Flanagan, M.D., B.Ch., reviews how to diagnose autoimmune encephalitis, what to watch that may suggest a different diagnosis, discuss neural autoantibodies interpretation and putting test results into clinical context.

In this episode of Mayo Clinic Laboratories “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, and Shannon Bennett, director of regulatory affairs for Mayo Clinic’s Department of Laboratory Medicine and Pathology, discuss the regulatory environment, its impact on outreach laboratories, and how lab staff can best stay on top of changing laboratory regulations.

Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing new tests but finding ways to make existing tests more efficient and easier for patients.